gene therapy
Vision fighter: Durham gene therapy startup lands $24.5M with clinical trial underway
Posted by WRAL TechWire | Oct 2, 2023
Atsena Therapeutics – a clinical-stage gene therapy company that’s fighting to reverse and prevent blindness and recently launched a clinical trial for a possible treatment, has landed $24.5 million from investors to carry on the battle.
Read MorePharma giant Astellas, which operates $100M gene therapy plant in Sanford, invests $50M in San Diego biotech
Posted by WRAL TechWire | Aug 7, 2023
Global pharmaceutical firm Astellas, which operates a $100 million gene therapy manufacturing plant in Sanford, is investing $50 million in San Diego-based Poseida Therapeutics.
Read More‘Gene therapy redefined:’ Biotech with ops in Durham, California, raises $150M
Posted by WRAL TechWire | Jul 28, 2023
Durham biotech Kriya Therapeutics which says it represents “gene therapy redefined,” has raised $150 million for its gene therapy programs.
Read MoreRTP gene therapy company StrideBio sells intellectual property
Posted by WRAL TechWire | Apr 18, 2023
StrideBio, a gene therapy company based in Research Triangle Park, has sold its intellectual property to Ginkgo Bioworks of Boston.
Read MoreDurham gene therapy firm Kriya adds $270M in Series C funding to advance pipeline, expand in Triangle
Posted by Jason Parker | May 16, 2022
Kriya Therapeutics, Inc., a gene therapy company with locations in California and RTP, has raised $270 million more in capital.
Read MoreAskBio CEO Sheila Mikhail wages two-front battle against diseases – her own, other genetic threats
Posted by WRAL TechWire | Mar 8, 2022
Seventeen months after negotiating a whopping $4 billion buyout deal with German pharma giant Bayer, Asklepios BioPharmaceutical (AskBio) CEO and co-founder Sheila Mikhail says the pioneering gene therapy company is hitting all its targets. And she continues to wage her own battle with lupus.
Read MoreBoost for NC gene therapy companies – a new rare disease consortium
Posted by WRAL TechWire | Dec 20, 2021
The NIH and FDA along with a cadre of pharmaceutical companies and non-profit organizations have teamed up to speed the development of new gene therapy treatments. It’s good news for North Carolina as well, which is home to close to 50 gene therapy and rare disease-focused businesses that provide jobs for several thousand Tar Heel residents.
Read MoreFrom gene therapies to medical treatments, cutting-edge research finds a home in NC
Posted by WRAL TechWire | Dec 8, 2021
From more nutritious plants to advanced treatments for neurological conditions, the life sciences companies around North Carolina are fueling research breakthroughs with global impacts.
Read More